The immunosuppressive role of Edn3 overexpression in the melanoma microenvironment-Reference-Cited by-同舟云学术

The immunosuppressive role of Edn3 overexpression in the melanoma microenvironment

Published:2021-07-29 Issue:6 Volume:34 Page:1084-1093
ISSN:1755-1471
Container-title:Pigment Cell & Melanoma Research
language:en
Short-container-title:Pigment Cell Melanoma Res

Author:

Freitas Juliano T.¹^ORCID,Lopez Jesus¹,Llorian Claudia¹,Boroni Mariana²,Kos Lidia¹³^ORCID

Affiliation:

1. Department of Biological Sciences Florida International University Miami FL USA

2. Division of Experimental and Translational Research Bioinformatics and Computational Biology Lab Brazilian National Cancer Institute Rio de Janeiro Brazil

3. Biomolecular Sciences Institute Florida International University Miami FL USA

Publisher

Wiley

Subject

Dermatology,General Biochemistry, Genetics and Molecular Biology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pcmr.13002

Reference43 articles.

1. Endothelin-Receptor Antagonists beyond Pulmonary Arterial Hypertension: Cancer and Fibrosis

2. Endothelin B Receptor Blockade Inhibits Dynamics of Cell Interactions and Communications in Melanoma Cell Progression

3. Stromal endothelin B receptor–deficiency inhibits breast cancer growth and metastasis

4. Molecular classification of cutaneous malignant melanoma by gene expression profiling

5. Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endothelin and the tumor microenvironment: a finger in every pie;Clinical Science;2024-05-24

2. LRP1B mutation is associated with tumor immune microenvironment and progression-free survival in lung adenocarcinoma treated with immune checkpoint inhibitors;Translational Lung Cancer Research;2023-03

3. Comprehensive analysis of immune-related genes associated with the microenvironment of patients with unexplained infertility;Annals of Translational Medicine;2023-01

4. Targeting GPCRs and Their Signaling as a Therapeutic Option in Melanoma;Cancers;2022-01-29